The Cancer Therapeutics Program consists of a collaborative network of basic science and clinical investigators spanning a range of experimental and developmental therapeutics. The Program serves as a hub for translating cancer-related discoveries into clinical trials that seek to ultimately benefit patients in the UC Davis Comprehensive Cancer Center catchment area. The Program's mission is to discover new biomarkers and molecular targets for cancer therapeutics, to accelerate the rate of the new agent development, and to translate basic science and preclinical findings to patient care through clinical trials.

The Program's specific aims include: (1) developing and applying new tools for discovery of new biomarkers, therapeutic targets, novel imaging techniques, and lead compounds, (2) developing new antineoplastic drugs and innovative drug-deliver modalities, and (3) developing and conducting hypothesis-driven clinical trials based on strong preclinical rationale.

View Cancer Therapeutics members